Explore the words cloud of the ELBA project. It provides you a very rough idea of what is the project "ELBA" about.
The following table provides information about the project.
|Coordinator Country||Netherlands [NL]|
|Total cost||3˙727˙722 €|
|EC max contribution||3˙727˙722 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2018-01-01 to 2021-12-31|
Take a look of project's partnership.
|1||STICHTING VUMC||NL (AMSTERDAM)||coordinator||510˙748.00|
|2||CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER||FR (MONTPELLIER)||participant||525˙751.00|
|3||UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF||DE (HAMBURG)||participant||498˙432.00|
|4||INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL||ES (BADALONA BARCELONA)||participant||495˙745.00|
|5||UNIVERSIDAD DE GRANADA||ES (GRANADA)||participant||495˙745.00|
|6||FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD||PT (LISBOA)||participant||476˙712.00|
|7||EXOSOMICS SIENA SPA||IT (SIENA)||participant||258˙061.00|
|8||PANGAEA BIOTECH SL||ES (BARCELONA)||participant||247˙872.00|
|9||PLOVDIVSKI UNIVERSITET PAISIY HILENDARSKI||BG (PLOVDIV)||participant||218˙651.00|
|10||EUROPEAN CANCER PATIENT COALITION||BE (BRUXELLES)||partner||0.00|
|11||Factory-CRO BV||NL (Bilthoven)||partner||0.00|
|12||GenomeScan B.V.||NL (Leiden)||partner||0.00|
|13||GILUPI GMBH||DE (POSTDAM)||partner||0.00|
|14||IZON SCIENCE LIMITED||UK (OXFORD)||partner||0.00|
|15||Sense About Science||UK (London)||partner||0.00|
|16||TATAA BIOCENTER AB||SE (GOTEBORG)||partner||0.00|
|17||TTOPSTART BV||NL (UTRECHT)||partner||0.00|
|18||UNIVERSITEIT TWENTE||NL (ENSCHEDE)||partner||0.00|
|19||University of Padova||IT (Padua)||partner||0.00|
|20||University of Szeged||US (CAMBRIDGE)||partner||0.00|
|21||V.O. Patents & Trademarks||DE (Munich)||partner||0.00|
Liquid biopsies have been heralded as a game changer in cancer management, with blood tests offering a minimally invasive, safe, and sensitive alternative or complimentary approach for tissue biopsies. Blood represents a rich source of information through which solid cancers (and their subtypes) can be detected, identified and classified, and matched to a specific therapy. However, despite the potential of individual approaches, the promise of liquid biopsies has not yet materialised in the clinic. Widespread deployment requires creative next-generation researchers with an innovative mindset with access to a unique toolbox, including medical know-how, molecular diagnostics expertise (from health economics to regulatory), and statistical/bioinformatical proficiency. Currently, there are no comprehensive training programmes to address this need. To move the promising liquid biopsy technology out of its infancy, the research programme and educational curriculum of the European Liquid Biopsy Academy (ELBA) will cover the entire value chain of diagnostics development and integrate all required disciplines and sectors.
ELBA will educate 15 Early Stage Researchers (ESRs) with the skills to circumvent the obstacles currently hampering effective development and commercialisation of liquid biopsy approaches. By creating a sustainable network to foster long-term multidisciplinary relationships and communication networks with various stakeholders we aim to accelerate clinical translation of these blood-based diagnostics. Most importantly, we have designed a well-balanced training programme to provide excellent career opportunities for the 15 ELBA ESRs. this includes training on state-of-the-art technologies and tools; bioinformatics, biostatistics and mathematical modelling; health economics and health technology assessment; diagnostic test development (including intellectual property and regulatory affairs); transferable skills (including leadership) and patient inclusion.
|First online version of network public website||Other||2019-06-19 14:53:28|
|Call for applications||Other||2019-06-19 14:53:28|
Take a look to the deliverables list in detail: detailed list of ELBA deliverables.
|year||authors and title||journal||last update|
J W P Bracht, J Berenguer, N Karachaliou, M Filipska, R Rosell
Combining plasma-based biosources to predict treatment response in NSCLC patients
published pages: 2022-2022, ISSN: 0923-7534, DOI: 10.1093/annonc/mdy246
|Annals of Oncology 29/9||2019-11-22|
Martyna Filipska, Carlos Pedraz-Valdunciel, Imane Chaib, Rafael Rosell
Biological therapies in lung cancer treatment: using our immune system as an ally to defeat the malignancy
published pages: 457-467, ISSN: 1471-2598, DOI: 10.1080/14712598.2019.1582635
|Expert Opinion on Biological Therapy 19/5||2019-11-22|
Niki Karachaliou, Jordi Codony-Servat, Jillian Wilhelmina Paulina Bracht, Masaoki Ito, Martyna Filipska, Carlos Pedraz, Imane Chaib, Jordi Bertran-Alamillo, Andres Felipe Cardona, Miguel Angel Molina, Rafael Rosell
Characterising acquired resistance to erlotinib in non-small cell lung cancer patients
published pages: 1019-1028, ISSN: 1747-6348, DOI: 10.1080/17476348.2019.1656068
|Expert Review of Respiratory Medicine 13/10||2019-11-22|
Ernesto Aparicio-Puerta, Ricardo LebrÃ³n, Antonio Rueda, Cristina GÃ³mez-MartÃn, Stavros Giannoukakos, David Jaspez, JosÃ© MarÃa Medina, Andreja Zubkovic, Igor Jurak, Bastian Fromm, Juan Antonio Marchal, JosÃ© Oliver, Michael Hackenberg
sRNAbench and sRNAtoolbox 2019: intuitive fast small RNA profiling and differential expression
published pages: W530-W535, ISSN: 0305-1048, DOI: 10.1093/nar/gkz415
|Nucleic Acids Research 47/W1||2019-10-30|
Myron G. Best, Sjors G. J. G. In â€™t Veld, Nik Sol, Thomas Wurdinger
RNA sequencing and swarm intelligenceâ€“enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA
published pages: , ISSN: 1754-2189, DOI: 10.1038/s41596-019-0139-5
Ernesto Aparicio-Puerta, David JÃ¡spez, Ricardo LebrÃ³n, Danijela Koppers-Lalic, JuanÂ A Marchal, Michael Hackenberg
liqDB: a small-RNAseq knowledge discovery database for liquid biopsy studies
published pages: D113-D120, ISSN: 0305-1048, DOI: 10.1093/nar/gky981
|Nucleic Acids Research 47/D1||2019-06-19|
Jillian Wilhelmina Paulina Bracht, Clara Mayo-de-las-Casas, Jordi Berenguer, Niki Karachaliou, Rafael Rosell
The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring
published pages: , ISSN: 1523-3790, DOI: 10.1007/s11912-018-0720-z
|Current Oncology Reports 20/9||2019-06-19|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ELBA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ELBA" are provided by the European Opendata Portal: CORDIS opendata.